Nanjing Huaxun and Taiwan Qingchen Law Firm hosted the 3rd Forward China Medical Materials and Pharmaceutical Market Forum

2018Year8Month26The Political Bureau of the CPC Central Committee deliberated and approved the "healthy China"2030"In the outline of the plan, the meeting pointed out that" health is an inevitable requirement for promoting people's all-round development, a basic condition for economic and social development, an important symbol of national prosperity and national prosperity, and the common pursuit of the broad masses of people." From a global perspective, the health industry has always been a popular industry that is booming, and it is an industry that my country strongly supports and develops.

In developed countries, the value added of the health industry accountsGDPSpecific gravity exceeds15%In our country, it only accounts for the gross national product.4%～5%This is lower than in many developing countries. On the other side of the Taiwan Strait, the development of the health industry in Taiwan is relatively mature, especially in new drugs such as cancer, infectious diseases, and immune diseases, medical equipment that combines the advantages of the electronic industry, as well as variety improvement and basic agricultural products based on genetic body technology research and development. Industries such as agricultural biotechnology have great advantages.

In order to further enhance the health industry cooperation between the mainland and Taiwan,2018Year12Month5On the same day, Taiwan Qingchen Law firm and Nanjing Huaxun intellectual property Consulting Co., Ltd. jointly with enterprises and institutions related to the health industry on both sides of the strait went to Taiwan to gather ideas at the National Taiwan University Conference Center.-Socrates Hall held the third Greater China Economic Circle medical biotechnology industry forum.

The forum focused on the four sections of registration regulations, legal intelligence, capital investment, and marketing of the pharmaceutical and medical industry in mainland China. It introduced in detail the relevant policies and regulations for the development of the health industry in the mainland to Taiwanese biotechnology companies that are interested in investing in mainland China. And market environment. At the same time, the forum will build a cross-strait exchange platform to allow biotechnology companies in the mainland to understand the advanced scientific research and production technology of Taiwanese biotechnology companies.

However, whether in the mainland or Taiwan, intellectual property rights are an unavoidable problem for the biotechnology industry. General Manager Hou Qingchen, General Manager of Nanjing Huaxun Intellectual Property (also the founding lawyer and executive partner of Taiwan Qingchen Firm), shared the "Challenge to International Pharmaceutical Factory's Heavy Drug Patents in China" at this forum.(blockbuster drugs patent challenge) --Cases and Experiences "IP-related topics. General Manager Hou took the actual combat experience of invalid patents in the mainland as a case, deeply analyzed the development status of the biotechnology industry in mainland China and the environment for the development of intellectual property rights, and pointed out the way and direction for Taiwan's pharmaceutical companies to enter the mainland.

It is worth mentioning that General Manager Hou Qingchen is a Ph.D. in intellectual property from Peking University Law School, and also holds a master's degree in law from National Taiwan University, a master's degree in business from National Chengchi University and a master's degree in law from the University of Pennsylvania in the United States. He once worked in a Taiwanese intellectual law firm and Internationally renowned law firmBaker&Mckenzie. He has a license for Taiwan lawyer, Taiwan patent engineer, New York State lawyer, etc., has 15 years of professional experience in transnational intellectual property rights, is familiar with the laws of Taiwan, the United States and the mainland, and is familiar with the industrial operation of Taiwan, the mainland and overseas.

The convening of this forum will build a bridge for in-depth exchanges and communication between the two sides of the strait in the biotechnology and health industry, and realize the complementary advantages and win-win development of both sides of the strait.